Braskem S.A. ADR (BAK) Shares Have Declined -1.04% Year To Date

Braskem S.A. ADR (NYSE:BAK) has a beta value of 1.77 and has seen 1.42 million shares traded in the last trading session. The company, currently valued at $659.06M, closed the last trade at $3.82 per share which meant it gained $0.31 on the day or 8.83% during that session. The BAK stock price is -141.1% off its 52-week high price of $9.21 and 25.39% above the 52-week low of $2.85. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.07 million shares traded. The 3-month trading volume is 866.92K shares.

Braskem S.A. ADR (NYSE:BAK) trade information

Sporting 8.83% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the BAK stock price touched $3.82 or saw a rise of 0.26%. Year-to-date, Braskem S.A. ADR shares have moved -1.04%, while the 5-day performance has seen it change 9.77%. Over the past 30 days, the shares of Braskem S.A. ADR (NYSE:BAK) have changed 1.87%. Short interest in the company has seen 2.72 million shares shorted with days to cover at 3.19.

Wall Street analysts have a consensus price target for the stock at $9.25, which means that the shares’ value could jump 58.7% from current levels. The projected low price target is $8.5 while the price target rests at a high of $10.0. In that case, then, we find that the current price level is -161.78% off the targeted high while a plunge would see the stock gain -122.51% from current levels.

Braskem S.A. ADR (BAK) estimates and forecasts

The company’s shares have lost -40.50% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 14.65%.

4 analysts offering their estimates for the company have set an average revenue estimate of 21.99B for the current quarter. 2 have an estimated revenue figure of 21.71B for the next ending quarter. Year-ago sales stood 17.92B and 19.07B respectively for this quarter and the next, and analysts expect sales will grow by 22.73% for the current quarter and 14.65% for the next.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -24.21% over the past 5 years.

BAK Dividends

Braskem S.A. ADR is expected to release its next earnings report on 2025-Feb-26 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

Braskem S.A. ADR (NYSE:BAK)’s Major holders

Investors are also buoyed by the number of investors in a company, with Braskem S.A. ADR having a total of 76.0 institutions that hold shares in the company. The top two institutional holders are OAKTREE CAPITAL MANAGEMENT LP with over 2.44 million shares worth more than $15.76 million. As of 2024-06-30, OAKTREE CAPITAL MANAGEMENT LP held 0.613% of shares outstanding.

The other major institutional holder is MBB PUBLIC MARKETS I LLC, with the holding of over 1.6 million shares as of 2024-06-30. The firm’s total holdings are worth over $10.3 million and represent 0.4007% of shares outstanding.

Also the top two Mutual Funds that are holding company’s shares are VANGUARD Intl Eqy. INDEX Fd.S-Vanguard Emerging Markets Stock Index Fd and SPDR INDEX SHARES FUNDS-SPDR(R) Portfolio Emerging Markets ETF . As of Jan 31, 2025 , the former fund manager holds about 0.16% shares in the company for having 272.41 shares of worth $1.04 million while later fund manager owns 248.05 shares of worth $0.95 million as of Feb 28, 2025 , which makes it owner of about 0.14% of company’s outstanding stock.